SCHEMBL16596349

SCHEMBL16596349

CCC(C)COc1ccc2c(NCCCc3ccccc3)ncnc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.55
PIK3CD O00329 1/20 0.52
PIK3R1 P27986 1/20 0.52
DNMT1 P26358 4/20 0.50
DNMT3A Q9Y6K1 4/20 0.50
MAPK1 P28482 3/20 0.49
AURKA O14965 1/20 0.49
LMNA P02545 2/20 0.48
APP P05067 1/20 0.48
HTT P42858 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.44
S1PR2 O95136 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
TP53 P04637 2/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
TMIGD3 P0DMS9 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17994857 0.86 EGFR (0.61) EGFRPIK3CDPIK3R1DNMT1DNMT3A
SCHEMBL17994858 0.82 EGFR (0.58) EGFRPIK3CDPIK3R1DNMT1DNMT3A
SCHEMBL16596382 0.82 PIK3CD (0.60) EGFRPIK3CDPIK3R1DNMT1DNMT3A
SCHEMBL16586076 0.81 PIK3CD (0.58) EGFRPIK3CDPIK3R1DNMT1DNMT3A
SCHEMBL16585469 0.78 EGFR (0.48) EGFRPIK3CDPIK3R1DNMT1DNMT3A
SCHEMBL17994889 0.78 DNMT3A (0.67) EGFRPIK3CDPIK3R1DNMT1DNMT3A
SCHEMBL17994863 0.77 DNMT3A (0.66) EGFRPIK3CDPIK3R1DNMT1DNMT3A
SCHEMBL18103414 0.76 PIK3CD (0.62) EGFRPIK3CDPIK3R1MAPK1AURKA
SCHEMBL16596213 0.75 DNMT3A (0.64) EGFRPIK3CDPIK3R1DNMT1DNMT3A
SCHEMBL19563559 0.75 AURKA (0.51) EGFRPIK3CDPIK3R1DNMT1DNMT3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3046917-B1 QUINAZOLINE DERIVATIVES AND THEIR USE AS DNA METHYLTRANSFERASE INHIBITORS PF MEDICAMENT (FR) 2017-11-08 EP disclosed
WO-2015040169-A1 QUINAZOLINE DERIVATIVES AND THEIR USE AS DNA METHYLTRANSFERASE INHIBITORS PIERRE FABRE MEDICAMENT (FR) 2015-03-26 WO disclosed
US-8952016-B2 Substituted xanthine derivatives CONCERT PHARMACEUTICALS, INC. (US) 2015-02-10 US disclosed